Anticancer tobacco cembranoids

Details Anticancer tobacco cembranoids Anticancer tobacco cembranoids

2011-07-12

2011-07-12

Henley, III, Raymond J (Department: 1614)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Nitrogen containing other than solely as a nitrogen in an...

C514S617000

Reexamination Certificate

active

07977384

ABSTRACT:
In the specification and drawings a method of treating cancer is described and shown. The method includes delivering an amount of at least one compound to an area containing a cancer cell. A compound and a method of preparing a compound are also described and shown.

REFERENCES:
Khalid A. El Sayed and Paul W. Sylvester; “Biocatalytic and semisynthetic studies of the anticancer tobacco cembranoids”; Informa Healthcare, Expert Opinion, Investig. Drugs; (2007) 16(6):877-887.
Khalid A. El Sayed, Surat Laphookhieo, Hany N. Baraka, Muhammad Yousaf, Anne Hebert, Danielle Bagaley, Frederick A. Rainey, A. Muralidharan, Shibu Thomas and Girish V. Shah; Biocatalytic and semisynthetic optimization of the anti-invasive tobacco (1S,2E,4R,6R,7E,11E)-2,7,11-cembratriene-4,6-diol; ScienceDirect Biorganic & Medicinal Chemistry 16 (2008) 2886-2893.
Khalid A. El Sayed, Surat Laphookhieo, Muhammad Yousaf, Justin A. Prestridge, Amit B. Shirode, Vikram B. Wali, and Paul W Sylvester; Semisynthetic and Biotransformation Studies of (1S,2E,4S,6R,7E,11E)-2,7,11-Cembratriene-4,6-diol; J. Nat. Prod. 2008, 71, 117-122.

Affiliated with

Also associated with

Rating

Anticancer tobacco cembranoids does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anticancer tobacco cembranoids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anticancer tobacco cembranoids will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2629477